Log in to post a reply
Mar 25, 2010 09:21AM
Each of us are different on what we tolerate and what bothers us. I don't have any problems with the MRI - part of that is because it is so much better than the PET scans that I've had.
At the breast center I go to they have a very comfortable form that you lay face down on. Your face lays on a hollowed out area so it's just padding around the edge of the face and in the hollow area, where your mouth, nose and eyes are, air is being gently blown. I've done this locally and they don't have as nice a form and don't have the hollow area. Not as comfortable but doable. Your given a panic button in case you need immediate help. But the techs will be talking to you through speakers and they can also hear you. The 30 minutes is divided into multiple test that may last 30 sec, 1.5 min, 2.5, etc. The techs will be talking to you and letting you know how long the next test will last. So, in case you do have any issues, it is easy to stop, get you comfortable again and move through the next test.
During the test the machine will be making very noisy thumping, knocking sounds. Weird sounds, but I don't find it troubling.
Just a warning here. I was extremely disappointed at my local hospital when I got one of my MRIs. The techs did not talk to me to keep my informed of how long the next test was going to last or how much time was left. I just assumed that they would do that so I didn't explictly ask them. It was on the tip of my tongue and I should have said something. I find the tech talking to you is reassuring and let's you know that the test is progressing OK and will be ending soon.
I have more problems with the PET. With that scan you lay face up, get velcro'ed so you can't move, and then have to lay there for an hour to an hour and a half. In my case I'm part of an imaging study so they do 2 30-min scans and 2 1-hour scans. Three hours total. Not fun.
Christy - BRCA2+; mets to bones and liver, Taxol/Sutent -> AC, BMX - no recon, Rads, Carboplatin, BSO, Veliparib trial (8/30/13-3/13/14)
7/21/2009, ILC, 5cm, Stage IIIC, Grade 3, 14/17 nodes, ER+/PR+, HER2-
9/1/2010 Aromasin (exemestane)
9/9/2012 Femara (letrozole)
9/9/2012, ILC, Stage IV, Grade 3, ER+/PR-, HER2-
3/29/2013 Xeloda (capecitabine)
8/16/2013 Faslodex (fulvestrant)
3/20/2014 Carboplatin (Paraplatin)